Gene: KALRN
Official Full Name: kalirin RhoGEF kinaseprovided by HGNC
Gene Summary: Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein that interacts with the huntingtin-associated protein 1, which is a huntingtin binding protein that may function in vesicle trafficking. [provided by RefSeq, Apr 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33659 | KALRN Knockout cell line (HeLa) | Human | KALRN | 1:3~1:6 | Negative | Online Inquiry |
KO33660 | KALRN Knockout cell line (HCT 116) | Human | KALRN | 1:2~1:4 | Negative | Online Inquiry |
KO33661 | KALRN Knockout cell line (HEK293) | Human | KALRN | 1:3~1:6 | Negative | Online Inquiry |
KO33662 | KALRN Knockout cell line (A549) | Human | KALRN | 1:3~1:4 | Negative | Online Inquiry |
KALRN Gene Knockout Cell Lines represent a groundbreaking advancement in genetic research and therapeutic discovery. These specialized cell lines have been engineered to specifically disrupt the expression of the KALRN gene, which encodes for Kalirin-7, a Rho guanine nucleotide exchange factor. By utilizing CRISPR/Cas9 technology, these knockout lines facilitate the investigation of KALRN's roles in various biological processes, including cellular signaling pathways, neurodevelopment, and cancer progression.
The primary mechanism of action involves the insertion of a non-functional fragment within the KALRN gene. This targeted knockout induces a complete loss of gene function, enabling researchers to assess the phenotypic consequences of KALRN deficiency in diverse cellular contexts. These cells are invaluable for dissecting the molecular pathways influenced by Kalirin-7, offering potential insights into disease mechanisms and therapeutic targets.
Scientifically, KALRN Gene Knockout Cell Lines are essential tools in both basic and applied research, bridging the gap between molecular biology and clinical applications. Their utility spans various fields, including oncology, neuroscience, and regenerative medicine, where understanding the interplay of genes and cellular functions is critical.
The advantages of using KALRN Gene Knockout Cell Lines over traditional gene knockdown techniques, such as RNA interference, lie in their permanency and precision. Unlike transient knockdown approaches, which may yield variable results and can lead to off-target effects, knockout lines provide consistent and reproducible data. This high specificity translates into more reliable experimental outcomes, making them an attractive choice for researchers seeking robust genetic models.
For researchers and clinicians dedicated to advancing medical knowledge and developing new treatments, the KALRN Gene Knockout Cell Lines offer a unique opportunity to explore unexplored biological landscapes with confidence. With a commitment to excellence in biotechnology, our company brings unmatched expertise and high-quality products to the scientific community, empowering innovators to achieve groundbreaking discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.